Literature DB >> 21497738

Mechanisms of hepatic fibrogenesis.

Ursula E Lee1, Scott L Friedman.   

Abstract

Multiple etiologies of liver disease lead to liver fibrosis through integrated signaling networks that regulate the deposition of extracellular matrix. This cascade of responses drives the activation of hepatic stellate cells (HSCs) into a myofibroblast-like phenotype that is contractile, proliferative and fibrogenic. Collagen and other extracellular matrix (ECM) components are deposited as the liver generates a wound-healing response to encapsulate injury. Sustained fibrogenesis leads to cirrhosis, characterized by a distortion of the liver parenchyma and vascular architecture. Uncovering the intricate mechanisms that underlie liver fibrogenesis forms the basis for efforts to develop targeted therapies to reverse the fibrotic response and improve the outcomes of patients with chronic liver disease.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21497738      PMCID: PMC3079877          DOI: 10.1016/j.bpg.2011.02.005

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  101 in total

Review 1.  TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression.

Authors:  Li Yang; Yanli Pang; Harold L Moses
Journal:  Trends Immunol       Date:  2010-06-01       Impact factor: 16.687

2.  Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway.

Authors:  Steve S Choi; Wing-Kin Syn; Gamze F Karaca; Alessia Omenetti; Cynthia A Moylan; Rafal P Witek; Kolade M Agboola; Youngmi Jung; Gregory A Michelotti; Anna Mae Diehl
Journal:  J Biol Chem       Date:  2010-09-14       Impact factor: 5.157

Review 3.  Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.

Authors:  Scott L Friedman
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2004-12

4.  The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients.

Authors:  Edward J Gane; Frank Weilert; David W Orr; Geraldine F Keogh; Michael Gibson; Michelle M Lockhart; Christopher M Frampton; Kenneth M Taylor; Robin A J Smith; Michael P Murphy
Journal:  Liver Int       Date:  2010-05-18       Impact factor: 5.828

5.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

6.  Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model.

Authors:  Nicholas G Theodorakis; Yining N Wang; Jian-Ming Wu; Mary A Maluccio; James V Sitzmann; Nicholas J Skill
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-07-23       Impact factor: 4.052

7.  Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cells.

Authors:  Lars P Bechmann; Denis Zahn; Robert K Gieseler; Christian D Fingas; Guido Marquitan; Christoph Jochum; Guido Gerken; Scott L Friedman; Ali Canbay
Journal:  Hepatol Res       Date:  2009-01-14       Impact factor: 4.288

8.  Connective tissue growth factor, steatosis and fibrosis in patients with chronic hepatitis C.

Authors:  Caroline Hora; Francesco Negro; Giacchino Leandro; Carl M Oneta; Laura Rubbia-Brandt; Beat Muellhaupt; Beat Helbling; Raffaele Malinverni; Jean-Jacques Gonvers; Jean-François Dufour
Journal:  Liver Int       Date:  2007-11-01       Impact factor: 5.828

9.  Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.

Authors:  Won-il Jeong; Douglas Osei-Hyiaman; Ogyi Park; Jie Liu; Sándor Bátkai; Partha Mukhopadhyay; Norio Horiguchi; Judith Harvey-White; Giovanni Marsicano; Beat Lutz; Bin Gao; George Kunos
Journal:  Cell Metab       Date:  2008-03       Impact factor: 27.287

10.  Regulation of endothelin-1 synthesis by endothelin-converting enzyme-1 during wound healing.

Authors:  R Shao; W Yan; D C Rockey
Journal:  J Biol Chem       Date:  1999-01-29       Impact factor: 5.157

View more
  306 in total

1.  Osteopontin contributes to TGF-β1 mediated hepatic stellate cell activation.

Authors:  Xiao Xiao; Yi Gang; Yong Gu; Lina Zhao; Jindong Chu; Jinfeng Zhou; Xiqiang Cai; Hui Zhang; Li Xu; Yongzhan Nie; Kaichun Wu; Zhiguo Liu; Daiming Fan
Journal:  Dig Dis Sci       Date:  2012-06-04       Impact factor: 3.199

2.  Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies.

Authors:  Allyson K Martínez; Luca Maroni; Marco Marzioni; Syed T Ahmed; Mena Milad; Debolina Ray; Gianfranco Alpini; Shannon S Glaser
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

3.  Macrophage migration inhibitory factor is required for recruitment of scar-associated macrophages during liver fibrosis.

Authors:  Mark A Barnes; Megan R McMullen; Sanjoy Roychowdhury; Nabil Z Madhun; Kathryn Niese; Mitchell A Olman; Abram B Stavitsky; Richard Bucala; Laura E Nagy
Journal:  J Leukoc Biol       Date:  2014-11-14       Impact factor: 4.962

4.  Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.

Authors:  Maria Eduarda Rocha de França; Sura Wanessa Santos Rocha; Wilma Helena Oliveira; Laise Aline Santos; Anne Gabrielle Vasconcelos de Oliveira; Karla Patrícia Sousa Barbosa; Ana Karolina Santana Nunes; Gabriel Barros Rodrigues; Deniele Bezerra Lós; Christina Alves Peixoto
Journal:  Inflammopharmacology       Date:  2017-04-13       Impact factor: 4.473

5.  Hepatic stimulator substance alleviates toxin-induced and immune-mediated liver injury and fibrosis in rats.

Authors:  Xuerui Yi; Ming Song; Youcheng Yuan; Xinrui Zhang; Wenyin Chen; Jin Li; Minghua Tong; Guangze Liu; Song You; Xiangping Kong
Journal:  Dig Dis Sci       Date:  2012-04-27       Impact factor: 3.199

6.  Hepatoprotective Effect of Probiotic Lactic Acid Bacteria on Thioacetamide-Induced Liver Fibrosis in Rats.

Authors:  Chittapon Jantararussamee; Siripa Rodniem; Malai Taweechotipatr; Udomsri Showpittapornchai; Wisuit Pradidarcheep
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02       Impact factor: 4.609

7.  Multiplex protein analysis to determine fibrosis stage and progression in patients with chronic hepatitis C.

Authors:  Keyur Patel; Katja S Remlinger; Terence G Walker; Peter Leitner; Joseph E Lucas; Stephen D Gardner; John G McHutchison; Will Irving; Indra Neil Guha
Journal:  Clin Gastroenterol Hepatol       Date:  2014-05-09       Impact factor: 11.382

Review 8.  Putting it all together: established and emerging MRI techniques for detecting and measuring liver fibrosis.

Authors:  Suraj D Serai; Andrew T Trout; Alexander Miethke; Eric Diaz; Stavra A Xanthakos; Jonathan R Dillman
Journal:  Pediatr Radiol       Date:  2018-08-04

9.  TGF-β1 signaling activates hepatic stellate cells through Notch pathway.

Authors:  Yasen Aimaiti; Maimaitinijiati Yusufukadier; Wending Li; Tusun Tuerhongjiang; Apar Shadike; Aisan Meiheriayi; Aini Abudusalamu; Hui Wang; Aji Tuerganaili; Yingmei Shao; Hao Wen
Journal:  Cytotechnology       Date:  2019-08-01       Impact factor: 2.058

Review 10.  Non-invasive diagnosis of liver fibrosis in chronic hepatitis C.

Authors:  Leonardo de Lucca Schiavon; Janaína Luz Narciso-Schiavon; Roberto José de Carvalho-Filho
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.